Megan Huizenga
Affiliations: | 2014- | Pharmacology | Georgetown University, Washington, DC |
Google:
"Megan Huizenga"Mean distance: 15.09 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentor| Ludise Malkova | grad student | Georgetown | |
| Patrick A. Forcelli | grad student | 2014-2018 | Georgetown |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Culjat M, Huizenga MN, Forcelli PA. (2020) Age-dependent anticonvulsant actions of perampanel and brivaracetam in the methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM) model of seizures in developing rats. Pharmacological Reports : Pr |
| Huizenga MN, Sepulveda-Rodriguez A, Forcelli PA. (2019) Preclinical safety and efficacy of cannabidivarin for early life seizures. Neuropharmacology. 148: 189-198 |
| Huizenga MN, Forcelli PA. (2018) Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but Not Phenobarbital-Induced Neurotoxicity in Immature Rats. Neurotoxicity Research |
| Huizenga MN, Fureman BE, Soltesz I, et al. (2018) Proceedings of the Epilepsy Foundation's 2017 Cannabinoids in Epilepsy Therapy Workshop. Epilepsy & Behavior : E&B |
| Queenan BN, Dunn RL, Santos VR, et al. (2017) Kappa opioid receptors regulate hippocampal synaptic homeostasis and epileptogenesis. Epilepsia |
| Huizenga MN, Wicker E, Beck VC, et al. (2017) Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats. Epilepsia |